AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

CUSIP: 037326105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
37,347,828
Total 13F shares
9,496,676
Share change
+109,958
Total reported value
$165,051,000
Price per share
$17.38
Number of holders
35
Value change
+$1,938,968
Number of buys
18
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 037326105?
CUSIP 037326105 identifies ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) as of Q3 2022

As of 30 Sep 2022, AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,496,676 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, CITADEL ADVISORS LLC, Avidity Partners Management LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Monashee Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, CITIGROUP INC, and Alyeska Investment Group, L.P.. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.